Behçet’s Disease Uveitis

Behçet’s Disease Uveitis

Uveitis in Behçet’s disease (BD) is frequent (40% of cases) and is a major cause of morbidity. The age of onset of uveitis is between 20 and 30 years. Ocular involvement includes anterior, posterior, or panuveitis. Uveitis may be the first sign of the disease in 20% of cases or it may appear 2 or 3...

Full description

Bibliographic Details
Main Authors:	Morgane Joubert, Anne-Claire Desbois, Fanny Domont, Amine Ghembaza, Alexandre Le Joncour, Adrien Mirouse, Georgina Maalouf, Mathilde Leclercq, Sarah Touhami, Patrice Cacoub, Bahram Bodaghi, David Saadoun
Format:	Article
Language:	English
Published:	MDPI AG 2023-05-01
Series:	Journal of Clinical Medicine
Subjects:	Behçet’s disease uveitis vasculitis biotherapies anti TNF-α agents
Online Access:	https://www.mdpi.com/2077-0383/12/11/3648

Similar Items

Biotherapies in Uveitis
by: Mathilde Leclercq, et al.
Published: (2020-11-01)

Ocular involvement in pediatric Behçet’s disease: is it different than in adults? (a short case series and mini review)
by: Casem Azri, et al.
Published: (2023-11-01)

Old and New Challenges in Uveitis Associated with Behçet’s Disease
by: Julie Gueudry, et al.
Published: (2021-05-01)

Pattern and Visual Prognostic Factors of Behcet’s Uveitis in Northwest Iran
by: Leila Alizadeh Ghavidel, et al.
Published: (2022-05-01)

Comparison of Sociodemographic Features Between Behçet Uveitis and Other Non-infectious Uveitis
by: F. Nilüfer Yalçındağ, et al.
Published: (2021-08-01)

Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study
by: Masaru Takeuchi, et al.
Published: (2023-01-01)

Behçet’s Uveitis: Current Diagnostic and Therapeutic Approach
by: Pınar Çakar Özdal
Published: (2020-06-01)

Vitreomacular Interface Disorders in Behçet’s Uveitis
by: Hilal Eser Öztürk, et al.
Published: (2017-12-01)

Features of systemic cytokine production in Behcet's disease associated with uveitis without ocular lesions
by: E. S. Sorozhkina, et al.
Published: (2021-11-01)

Ocular Manifestations of Behçet’s Disease: An Update on Diagnostic Challenges and Disease Management
by: Hanna Zając, et al.
Published: (2021-11-01)

Comparative effectiveness of various immunosuppressive therapy regimens for uveitis in patients with Behçet’s disease
by: T. A. Lisitsyna, et al.
Published: (2021-05-01)

The Effect of Vision-Related Quality of Life on Depression and Anxiety in Patients with Behçet Uveitis
by: Hilal Eser-Öztürk, et al.
Published: (2021-12-01)

Evaluation of Serum Homocysteine and Leptin Levels in Patients with Uveitis
by: Arif Emre Elbay, et al.
Published: (2015-08-01)

Twenty Years of Quiescence after Nonstop Remicade® (Infliximab) Infusions in a Child with Ocular Behçet Disease Presenting as Hypopyon-Anterior Uveitis Refractory to Immunosuppressants
by: Cem Evereklioglu
Published: (2023-02-01)

Profiling tear proteomes of patients with unilateral relapsed Behcet’s disease-associated uveitis using data-independent acquisition proteomics
by: Anyi Liang, et al.
Published: (2020-06-01)

Half-fluence Photodynamic Therapy for Central Serous Chorioretinopathy in a Patient Receiving Corticosteroids for Behçet’s Uveitis
by: Hüseyin Baran Özdemir, et al.
Published: (2022-04-01)

Celiac Disease Antibody Frequency in Idiopathic Uveitis Patients
by: Rıdvan Mercan
Published: (2017-07-01)

The intraocular CD4/CD8 ratio in a black South African patient with Behçet’s disease uveitis
by: A Makgotloe
Published: (2017-01-01)

Pediatric Uveitis
by: Ilknur Tugal-Tutkun
Published: (2011-01-01)

Patterns of uveitis at a tertiary referral center in Northeastern Iran
by: Seyedeh Maryam Hosseini, et al.
Published: (2018-01-01)

EFFECT OF HUMAN HERPES VIRUS REACTIVATION ON SYSTEMIC CYTOKINE PRODUCTION IN PATIENTS WITH BEHCET’S DISEASE AND UVEITIS
by: G. I. Krichevskaya, et al.
Published: (2021-10-01)

Evaluation of uveitis activity in Behcet's disease patients using BOS24
by: V. V. Neroev, et al.
Published: (2018-10-01)

Advances in pathogenesis and treatment of ocular involvement in Behcet’s disease
by: Suibin Lin, et al.
Published: (2023-09-01)

Uveitis-induced Refractory Ocular Hypotony Managed with High-dose Latanoprost
by: Fariba Ghassemi, et al.
Published: (2020-08-01)

Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
by: Biao Li, et al.
Published: (2023-07-01)

Clinical profile and management with immunosuppressants and biologics in Behcet's uveitis: A cohort of 25 patients from a tertiary eye care center in South India
by: Jeyasooriya Ramdoss, et al.
Published: (2023-01-01)

Ocular Behçet Disease—Clinical Manifestations, Treatments and Outcomes According to Age at Disease Onset
by: Michael Ostrovsky, et al.
Published: (2023-02-01)

Identification of the immune-related biomarkers in Behcet’s disease by plasma proteomic analysis
by: Huan Liu, et al.
Published: (2023-06-01)

Uveitis as an Open Window to Systemic Inflammatory Diseases
by: Thomas El Jammal, et al.
Published: (2021-01-01)

Visual outcomes and factors predictive of visual loss in Behcet's disease in Sultan Qaboos University Hospital, Oman
by: Nadiya Al Kharousi, et al.
Published: (2022-01-01)

Characteristics of macular edema in behcet disease after intravitreal bevacizumab injection
by: Fariba Ghassemi, et al.
Published: (2017-01-01)

Behçet’s disease and COVID-19, retrospective analysis
by: Mai Nasser Abd Elmohsen, et al.
Published: (2023-01-01)

Autoimmune uveitis in Behçet's disease and Vogt‐Koyanagi‐Harada disease differ in tissue immune infiltration and T cell clonality
by: Hao Kang, et al.
Published: (2023-01-01)

Case report: A case of neuro-Behçet's syndrome presenting as brain stem mass lesions
by: Folusakin Ayoade, et al.
Published: (2023-07-01)

Outcome of Pediatric Uveitis at an University Clinic
by: Berna Yüce, et al.
Published: (2013-12-01)

Anti-tumour necrosis factor-alpha agent therapy, compared with conventional therapy, reduces the relapse of uveitis in patients with behçet’s disease: A systematic review of controlled trials
by: Xinwei Zhou, et al.
Published: (2022-08-01)

Evaluation and Comparison of Choroidal Thickness in Patients with Behçet Disease with versus without Ocular Involvement
by: Seyedeh Maryam Hosseini, et al.
Published: (2021-05-01)

Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01)

Sociodemographic and Clinical Characteristics of Patients with Behçet’s Disease Followed Up in the Physical Therapy and Rehabilitation Department of a Tertiary Hospital
by: Nurdan Yılmaz, et al.
Published: (2021-04-01)

Research progress of NLRP3 inflammasome in the treatment of uveitis
by: Zhou Min, et al.
Published: (2024-04-01)